Printer Friendly

Medicure reports financial results for quarter ended 30 September 2016.

M2 PHARMA-November 10, 2016-Medicure reports financial results for quarter ended 30 September 2016

(C)2016 M2 COMMUNICATIONS

Medicure Inc (TSXV:MPH)( OTCQB:MCUJF), a specialty pharmaceutical company, has reported its financial results for the quarter ended 30 September 2016.

It was reported yesterday that the company posted net revenues of USD8.2m for the quarter ended 30September 2016, up 51% against USD5.4m in the year-ago period.

Adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA)1 for the quarter ended 30September 2016 was USD2.9 million compared to USD2.1 million for the quarter ended 30 September 2015.

The firm reported net income for the quarter ended 30 September 2016 at USD2m, compared to a net loss of USD348,000 in the same period in 2015.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Article Type:Financial report
Date:Nov 10, 2016
Words:138
Previous Article:Pfizer awarded approval for IBRANCE for treating women with HR+/HER2- metastatic breast cancer in the EU.
Next Article:Researchers at University of Illinois discover monobody that can block oncogene's activity.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters